IIB 
115TH CONGRESS 
2D SESSION 
H. R. 5925 
IN THE SENATE OF THE UNITED STATES 
JUNE 21, 2018 
Received; read twice and referred to the Committee on the Judiciary 
AN ACT 
To codify provisions relating to the Office of National Drug 
Control, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Coordinated Response 
through Interagency Strategy and Information Sharing 
Act’’ or the ‘‘CRISIS Act’’. 
SEC. 2. OFFICE OF NATIONAL DRUG CONTROL. 
(a) REDESIGNATION.—The Office of National Drug 
Control Policy shall be known as the ‘‘Office of National 
Drug Control’’. 
(b) REFERENCES.—Any reference in any other Fed-
eral law, Executive order, rule, regulation, or delegation 
of authority, or any document of or relating to the Office 
of National Drug Control Policy is deemed to refer to the 
Office of National Drug Control. 
(c) CODIFICATION.—Subtitle I of title 31, United 
States Code, is amended by adding at the end the fol-
lowing new chapter: 
‘‘CHAPTER 10—OFFICE OF NATIONAL 
DRUG CONTROL 
‘‘SUBCHAPTER I—OFFICE 
‘‘1001. Definitions. 
‘‘1002. Office of National Drug Control. 
‘‘1003. Administration of the Office. 
‘‘1004. National drug control program budget. 
‘‘1005. National drug control strategy. 
‘‘1006. Development of an annual national drug control assessment. 
‘‘1007. Monitoring and evaluation of national drug control program. 
‘‘1008. Coordination and oversight of the national drug control program. 
‘‘1009. Emerging threats task force, plan, campaign. 
‘‘1010. National and international coordination. 
‘‘1011. Interdiction. 
‘‘1012. Treatment coordinator. 
‘‘1013. Critical information coordination. 
‘‘1014. Authorization of appropriations. 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6211
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘SUBCHAPTER II—DRUG-FREE COMMUNITIES SUPPORT PROGRAM 
‘‘1021. Establishment of drug-free communities support program. 
‘‘1022. Program authorization. 
‘‘1023. Information collection and dissemination with respect to grant recipi-
ents. 
‘‘1024. Technical assistance and training. 
‘‘1025. Supplemental grants for coalition mentoring activities. 
‘‘1026. Authorization for National Community Antidrug Coalition Institute. 
‘‘1027. Definitions. 
‘‘1028. Drug–free communities reauthorization. 
‘‘SUBCHAPTER I—OFFICE 
‘‘§ 1001. Definitions 
‘‘In this chapter: 
‘‘(1) AGENCY.—The term ‘agency’ has the 
meaning given the term ‘executive agency’ in section 
102. 
‘‘(2) APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES.— 
‘‘(A) IN GENERAL.—The term ‘appropriate 
congressional committees’ means— 
‘‘(i) the Committee on the Judiciary, 
the Committee on Appropriations, the 
Committee on Health, Education, Labor, 
and Pensions, and the Caucus on Inter-
national Narcotics Control of the Senate; 
and 
‘‘(ii) the Committee on Oversight and 
Government Reform, the Committee on the 
Judiciary, the Committee on Energy and 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
Commerce, and the Committee on Appro-
priations of the House of Representatives. 
‘‘(B) SUBMISSION
TO
CONGRESS.—Any 
submission to Congress shall mean submission 
to the appropriate congressional committees. 
‘‘(3) DEMAND REDUCTION.—The term ‘demand 
reduction’ means any activity conducted by a Na-
tional Drug Control Program Agency, other than an 
enforcement activity, that is intended to reduce or 
prevent the use of drugs or support or provide treat-
ment and recovery efforts, including— 
‘‘(A) education about the dangers of illicit 
drug use; 
‘‘(B) services, programs, or strategies to 
prevent substance use disorder, including evi-
dence-based education campaigns, community- 
based prevention programs, collection and dis-
posal of unused prescription drugs, and services 
to at-risk populations to prevent or delay initial 
use of an illicit drug; 
‘‘(C) substance use disorder treatment; 
‘‘(D) illicit drug use research; 
‘‘(E) drug-free workplace programs; 
‘‘(F) drug testing, including the testing of 
employees; 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(G) interventions for illicit drug use and 
dependence; 
‘‘(H) expanding availability of access to 
health care services for the treatment of sub-
stance use disorders; 
‘‘(I) international drug control coordina-
tion and cooperation with respect to activities 
described in this paragraph; 
‘‘(J) pre- and post-arrest criminal justice 
interventions such as diversion programs, drug 
courts, and the provision of evidence-based 
treatment to individuals with substance use dis-
orders who are arrested or under some form of 
criminal justice supervision, including medica-
tion assisted treatment; 
‘‘(K) other coordinated and joint initiatives 
among Federal, State, local, and Tribal agen-
cies to promote comprehensive drug control 
strategies designed to reduce the demand for, 
and the availability of, illegal drugs; 
‘‘(L) international illicit drug use edu-
cation, prevention, treatment, recovery, re-
search, rehabilitation activities, and interven-
tions for illicit drug use and dependence; and 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(M) research related to any of the activi-
ties described in this paragraph. 
‘‘(4) DIRECTOR.—The term ‘Director’ means 
the Director of the Office of National Drug Control. 
‘‘(5) DRUG.—The term ‘drug’ has the meaning 
given the term ‘controlled substance’ in section 
102(6) of the Controlled Substances Act (21 U.S.C. 
802(6)). 
‘‘(6) DRUG CONTROL.—The term ‘drug control’ 
means any activity conducted by a National Drug 
Control Program Agency involving supply reduction 
or demand reduction. 
‘‘(7) EMERGING
DRUG
THREAT.—The term 
‘emerging drug threat’ means the occurrence of a 
new and growing trend in the use of an illicit drug 
or class of drugs, including rapid expansion in the 
supply of or demand for such drug. 
‘‘(8) ILLICIT DRUG USE; ILLICIT DRUGS; ILLE-
GAL
DRUGS.—The terms ‘illicit drug use’, ‘illicit 
drugs’, and ‘illegal drugs’ include the illegal or illicit 
use of prescription drugs. 
‘‘(9) LAW ENFORCEMENT.—The term ‘law en-
forcement’ or ‘drug law enforcement’ means all ef-
forts by a Federal, State, local, or Tribal govern-
ment agency to enforce the drug laws of the United 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
States or any State, including investigation, arrest, 
prosecution, and incarceration or other punishments 
or penalties. 
‘‘(10) NATIONAL DRUG CONTROL PROGRAM.— 
The term ‘National Drug Control Program’ means 
programs, policies, and activities undertaken by Na-
tional Drug Control Program Agencies pursuant to 
the responsibilities of such agencies under the Na-
tional Drug Control Strategy, including any activi-
ties involving supply reduction, demand reduction, or 
State, local, and Tribal affairs. 
‘‘(11) NATIONAL
DRUG
CONTROL
PROGRAM 
AGENCY.—The term ‘National Drug Control Pro-
gram Agency’ means any agency (or bureau, office, 
independent agency, board, division, commission, 
subdivision, unit, or other component thereof) that is 
responsible for implementing any aspect of the Na-
tional Drug Control Strategy, including any agency 
that receives Federal funds to implement any aspect 
of the National Drug Control Strategy, but does not 
include any agency that receives funds for drug con-
trol activity solely under the National Intelligence 
Program or the Military Intelligence Program. 
‘‘(12) NATIONAL
DRUG
CONTROL
STRATEGY; 
STRATEGY.—The term ‘National Drug Control 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
Strategy’ or ‘Strategy’ means the strategy developed 
and submitted to Congress under section 1005. 
‘‘(13) NONPROFIT
ORGANIZATION.—The term 
‘nonprofit organization’ means an organization that 
is described in section 501(c)(3) of the Internal Rev-
enue Code of 1986 and exempt from tax under sec-
tion 501(a) of such Code. 
‘‘(14) OFFICE.—The term ‘Office’ means the 
Office of National Drug Control. 
‘‘(15) STATE, LOCAL, AND TRIBAL AFFAIRS.— 
The term ‘State, local, and Tribal affairs’ means do-
mestic activities conducted by a National Drug Con-
trol Program Agency that are intended to reduce the 
availability and use of illegal drugs, including— 
‘‘(A) coordination and enhancement of 
Federal, State, local, and Tribal law enforce-
ment drug control efforts; 
‘‘(B) coordination and enhancement of ef-
forts among National Drug Control Program 
Agencies and State, local, and Tribal demand 
reduction and supply reduction agencies; 
‘‘(C) coordination and enhancement of 
Federal, State, local, and Tribal law enforce-
ment initiatives to gather, analyze, and dissemi-
nate information and law enforcement intel-
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
ligence relating to drug control among domestic 
law enforcement agencies; and 
‘‘(D) other coordinated and joint initiatives 
among Federal, State, local, and Tribal agen-
cies to promote comprehensive drug control 
strategies designed to reduce the demand for, 
and the availability of, illegal drugs. 
‘‘(16) SUBSTANCE
USE
DISORDER
TREAT-
MENT.—The term ‘substance use disorder treat-
ment’ means an evidence-based, professionally di-
rected, deliberate, and planned regimen including 
evaluation, observation, medical monitoring, and re-
habilitative services and interventions such as 
pharmacotherapy, behavioral therapy, and individual 
and group counseling, on an inpatient or outpatient 
basis, to help patients with substance use disorder 
reach recovery. 
‘‘(17) SUPPLY REDUCTION.—The term ‘supply 
reduction’ means any activity or program conducted 
by a National Drug Control Program Agency that is 
intended to reduce the availability or use of illegal 
drugs in the United States or abroad, including— 
‘‘(A) law enforcement outside the United 
States; 
‘‘(B) domestic law enforcement; 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(C) source country programs, including 
economic development programs primarily in-
tended to reduce the production or trafficking 
of illicit drugs; 
‘‘(D) activities to control international traf-
ficking in, and availability of, illegal drugs, in-
cluding— 
‘‘(i) accurate assessment and moni-
toring of international drug production and 
interdiction programs and policies; and 
‘‘(ii) coordination and promotion of 
compliance with international treaties re-
lating to the production, transportation, or 
interdiction of illegal drugs; 
‘‘(E) activities to conduct and promote 
international law enforcement programs and 
policies to reduce the supply of drugs; 
‘‘(F) activities to facilitate and enhance the 
sharing of domestic and foreign intelligence in-
formation among National Drug Control Pro-
gram Agencies, relating to the production and 
trafficking of drugs in the United States and in 
foreign countries; 
‘‘(G) activities to prevent the diversion of 
drugs for their illicit use; and 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(H) research related to any of the activi-
ties described in this paragraph. 
‘‘§ 1002. Office of National Drug Control 
‘‘(a) ESTABLISHMENT OF OFFICE.—There is estab-
lished in the Executive Office of the President an Office 
of National Drug Control, which shall— 
‘‘(1) lead the national drug control effort, in-
cluding coordinating with Nation Drug Control Pro-
gram Agencies; 
‘‘(2) coordinate and oversee the implementation 
of the national drug control policy, including the Na-
tional Drug Control Strategy; 
‘‘(3) assess and certify the adequacy of Na-
tional Drug Control Programs and the budget for 
those programs; 
‘‘(4) monitor and evaluate the effectiveness of 
national drug control policy efforts, including the 
National Drug Control Program Agencies’ pro-
grams, by developing and applying specific goals and 
performance measurements and tracking program- 
level spending; 
‘‘(5) identify and respond to emerging drug 
threats related to illicit drug use; 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(6) administer and evaluate grant programs in 
furtherance of the National Drug Control Strategy; 
and 
‘‘(7) facilitate broad-scale information sharing 
and data standardization among Federal, State, and 
local entities to support the national drug control ef-
forts. 
‘‘(b) DIRECTOR OF NATIONAL DRUG CONTROL AND 
DEPUTY DIRECTOR.— 
‘‘(1) DIRECTOR.— 
‘‘(A) IN GENERAL.—There shall be at the 
head of the Office a Director who shall hold the 
same rank and status as the head of an execu-
tive department listed in section 101 of title 5. 
‘‘(B) APPOINTMENT.—The Director shall 
be appointed by the President, by and with the 
advice and consent of the Senate, and shall 
serve at the pleasure of the President. 
‘‘(2) DEPUTY DIRECTOR.— 
‘‘(A) IN GENERAL.—There shall be a Dep-
uty Director who shall report directly to the Di-
rector, be appointed by the President, and serve 
at the pleasure of the President. 
‘‘(B) RESPONSIBILITIES.—The Deputy Di-
rector shall— 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(i) carry out the responsibilities dele-
gated by the Director; and 
‘‘(ii) be responsible for effectively co-
ordinating with the each Coordinator es-
tablished under this chapter. 
‘‘(c) RESPONSIBILITIES.— 
‘‘(1) POLICIES, GOALS, OBJECTIVES, AND PRI-
ORITIES.—The Director shall assist the President in 
directing national drug control efforts, including es-
tablishing policies, goals, objectives, and priorities 
for the National Drug Control Program that are 
based on evidence-based research. 
‘‘(2) CONSULTATION.—To formulate the Na-
tional Drug Control policies, goals, objectives, and 
priorities, the Director— 
‘‘(A) shall consult with— 
‘‘(i) State and local governments; 
‘‘(ii) National Drug Control Program 
Agencies; 
‘‘(iii) each committee, working group, 
council, or other entity established under 
this chapter, as appropriate; 
‘‘(iv) the public; 
‘‘(v) appropriate congressional com-
mittees; and 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(vi) any other person in the discre-
tion of the Director; and 
‘‘(B) may— 
‘‘(i) establish advisory councils; 
‘‘(ii) acquire data from agencies; and 
‘‘(iii) request data from any other en-
tity. 
‘‘§ 1003. Administration of the Office 
‘‘(a) EMPLOYMENT.— 
‘‘(1) AUTHORITY OF THE DIRECTOR.—The Di-
rector may select, appoint, employ, and fix com-
pensation of such officers and employees of the Of-
fice as may be necessary to carry out the functions 
of the Office under this chapter. 
‘‘(2) PROHIBITIONS.— 
‘‘(A) GENERALLY.—No person shall serve 
as Director or Deputy Director while serving in 
any other position in the Federal Government. 
‘‘(B) PROHIBITION
ON
POLITICAL
CAM-
PAIGNING.—Any officer or employee of the Of-
fice who is appointed to that position by the 
President, by and with the advice and consent 
of the Senate, may not participate in Federal 
election campaign activities, except that such 
officer or employee is not prohibited by this 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
subparagraph from making contributions to in-
dividual candidates. 
‘‘(b) PROHIBITION ON THE USE OF FUNDS FOR PO-
LITICAL CAMPAIGNS OR BALLOT INITIATIVES.—No funds 
authorized under this chapter may be obligated for the 
purpose of influencing any Federal, State, or local election 
or ballot initiative. 
‘‘(c) PERSONNEL DETAILED TO OFFICE.— 
‘‘(1) EVALUATIONS.—Notwithstanding any pro-
vision of chapter 43 of title 5, the Director shall per-
form the evaluation of the performance of any em-
ployee detailed to the Office for purposes of the ap-
plicable performance appraisal system established 
under such chapter for any rating period, or part 
thereof, that such employee is detailed to the Office. 
‘‘(2) COMPENSATION.— 
‘‘(A) BONUS PAYMENTS.—Subject to the 
availability of appropriations, the Director may 
provide periodic bonus payments to any em-
ployee detailed to the Office. 
‘‘(B) RESTRICTIONS.—An amount paid 
under this paragraph to an employee for any 
period— 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(i) shall not be greater than 20 per-
cent of the basic pay paid or payable to 
such employee for such period; and 
‘‘(ii) shall be in addition to the basic 
pay of such employee. 
‘‘(C) AGGREGATE
AMOUNT.—The aggre-
gate amount paid during any fiscal year to an 
employee detailed to the Office as basic pay, 
awards, bonuses, and other compensation shall 
not exceed the annual rate payable at the end 
of such fiscal year for positions at level III of 
the Executive Schedule. 
‘‘(d) CONGRESSIONAL ACCESS TO INFORMATION.— 
The location of the Office in the Executive Office of the 
President shall not be construed as affecting access by 
Congress, or any committee of the House of Representa-
tives or the Senate, to any— 
‘‘(1) information, document, or study in the 
possession of, or conducted by or at the direction of 
the Director; or 
‘‘(2) personnel of the Office. 
‘‘(e) OTHER AUTHORITIES OF THE DIRECTOR.—In 
carrying out this chapter, the Director may— 
‘‘(1) use for administrative purposes, on a reim-
bursable basis, the available services, equipment, 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
personnel, and facilities of Federal, State, and local 
agencies; 
‘‘(2) procure the services of experts and con-
sultants in accordance with section 3109 of title 5 
relating to appointments in the Federal Service, at 
rates of compensation for individuals not to exceed 
the daily equivalent of the rate of pay payable under 
level IV of the Executive Schedule under section 
5311 of such title; and 
‘‘(3) use the mails in the same manner as any 
other agency. 
‘‘(f) GENERAL SERVICES ADMINISTRATION.—The 
Administrator of General Services shall provide to the Di-
rector, on a reimbursable basis, such administrative sup-
port services as the Director may request. 
‘‘§ 1004. National drug control program budget 
‘‘(a) BUDGET RECOMMENDATIONS.—Not later than 
July 1 of each year, the Director shall provide to the head 
of each National Drug Control Program Agency budget 
recommendations, including requests for specific initia-
tives that are consistent with the priorities of the Presi-
dent under the National Drug Control Strategy, which 
shall— 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(1) apply to the budget for the next fiscal year 
scheduled for formulation under chapter 11, and 
each of the 4 subsequent fiscal years; and 
‘‘(2) address funding priorities developed in the 
National Drug Control Strategy. 
‘‘(b) RESPONSIBILITIES OF NATIONAL DRUG CON-
TROL PROGRAM AGENCIES.— 
‘‘(1) IN GENERAL.—For each fiscal year, the 
head of each National Drug Control Program Agen-
cy shall transmit to the Director a copy of the pro-
posed drug control budget request of such agency at 
the same time as that budget request is submitted 
to their superiors (and before submission to the Of-
fice of Management and Budget) in the preparation 
of the budget of the President submitted to Con-
gress under section 1105(a). 
‘‘(2) SUBMISSION OF DRUG CONTROL BUDGET 
REQUESTS.—The head of each National Drug Con-
trol Program Agency shall ensure timely develop-
ment and submission to the Director of each pro-
posed drug control budget request transmitted pur-
suant to this subsection, in such format as may be 
designated by the Director with the concurrence of 
the Director of the Office of Management and Budg-
et. 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(3) CONTENT OF DRUG CONTROL BUDGET RE-
QUESTS.—A drug control budget request submitted 
by the head of a National Drug Control Program 
Agency under this subsection shall include all re-
quests for funds for any drug control activity under-
taken by such agency, including demand reduction, 
supply reduction, and State, local, and Tribal af-
fairs, including any drug law enforcement activities. 
If an activity has both drug control and nondrug 
control purposes or applications, such agency shall 
estimate by a documented calculation the total funds 
requested for that activity that would be used for 
drug control, and shall set forth in its request the 
basis and method for making the estimate. 
‘‘(c) REVIEW AND CERTIFICATION OF BUDGET RE-
QUESTS AND BUDGET SUBMISSIONS OF NATIONAL DRUG 
CONTROL PROGRAM AGENCIES.— 
‘‘(1) IN GENERAL.—The Director shall review 
each drug control budget request submitted to the 
Director under subsection (b). 
‘‘(2) REVIEW OF BUDGET REQUESTS.— 
‘‘(A) INADEQUATE REQUESTS.—If the Di-
rector concludes that a budget request sub-
mitted under subsection (b) is inadequate, in 
whole or in part, to implement the objectives of 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
the National Drug Control Strategy with re-
spect to the agency or program at issue for the 
year for which the request is submitted, the Di-
rector shall submit to the head of the applicable 
National Drug Control Program Agency a writ-
ten description identifying the funding levels 
and specific initiatives that would, in the deter-
mination of the Director, make the request ade-
quate to implement those objectives. 
‘‘(B) ADEQUATE REQUESTS.—If the Direc-
tor concludes that a budget request submitted 
under subsection (b) is adequate to implement 
the objectives of the National Drug Control 
Strategy with respect to the agency or program 
at issue for the year for which the request is 
submitted, the Director shall submit to the 
head of the applicable National Drug Control 
Program Agency a written statement con-
firming the adequacy of the request. 
‘‘(C) RECORD.—The Director shall main-
tain a record of each description submitted 
under subparagraph (A) and each statement 
submitted under subparagraph (B). 
‘‘(3) SPECIFIC REQUESTS.—The Director shall 
not confirm the adequacy of any budget request that 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
requests a level of funding that will not enable 
achievement of the goals of the National Drug Con-
trol Strategy, including— 
‘‘(A) requests funding for Federal law en-
forcement activities that do not adequately com-
pensate for transfers of drug enforcement re-
sources and personnel to law enforcement and 
investigation activities; 
‘‘(B) requests funding for law enforcement 
activities on the borders of the United States 
that do not adequately direct resources to drug 
interdiction and enforcement; 
‘‘(C) requests funding for substance use 
disorder treatment activities that do not provide 
adequate results and accountability measures; 
‘‘(D) requests funding for substance use 
disorder treatment activities that do not ade-
quately support and enhance Federal substance 
use disorder programs and capacity; and 
‘‘(E) requests funding for the operations 
and management of the Department of Home-
land Security that does not include a specific 
request for funds for the Office of Counter-
narcotics Enforcement to carry out its respon-
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
sibilities under section 878 of the Homeland Se-
curity Act of 2002 (6 U.S.C. 458). 
‘‘(4) AGENCY RESPONSE.— 
‘‘(A) IN GENERAL.—The head of a Na-
tional Drug Control Program Agency that re-
ceives a description under paragraph (2)(A) 
shall include the funding levels and initiatives 
described by the Director in the budget submis-
sion for that agency to the Office of Manage-
ment and Budget. 
‘‘(B) IMPACT STATEMENT.—The head of a 
National Drug Control Program Agency that 
has altered its budget submission under this 
paragraph shall include as an appendix to the 
budget submission for that agency to the Office 
of Management and Budget an impact state-
ment that summarizes— 
‘‘(i) the changes made to the budget 
under this paragraph; and 
‘‘(ii) the impact of those changes on 
the ability of that agency to perform its 
other responsibilities, including any impact 
on specific missions or programs of the 
agency. 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(C) CONGRESSIONAL
NOTIFICATION.— 
The head of a National Drug Control Program 
Agency shall submit a copy of any impact state-
ment under subparagraph (B) to the Senate, 
the House of Representatives, and the appro-
priate congressional committees, at the time the 
budget for that agency is submitted to Congress 
under section 1105(a). 
‘‘(5) CERTIFICATION
OF
BUDGET
SUBMIS-
SIONS.— 
‘‘(A) IN GENERAL.—At the time the head 
of a National Drug Control Program Agency 
submits its budget request to the Office of 
Management and Budget, the head of the Na-
tional Drug Control Program Agency shall sub-
mit a copy of the budget request to the Direc-
tor. 
‘‘(B) REVIEW
AND
CERTIFICATION
OF 
SUBMISSIONS.—The Director shall review each 
budget submission submitted under subpara-
graph (A) and submit to the appropriate con-
gressional committees one of the following: 
‘‘(i) A written certification of the 
budget submission for the agency indi-
cating such request fully funds the Na-
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
statement identifying the additional infor-
mation necessary for the Director to make 
a determination on such budget submission 
and the level of funding sufficient to 
achieve the goals of the Strategy. 
‘‘(iv) A written decertification of the 
budget submission for the agency indi-
cating that such budget is insufficient to 
fund the National Drug Control Programs 
as necessary to achieve the goals of the 
Strategy, including a written statement ex-
plaining the basis for the determination 
that the budget is insufficient and identi-
fying the level of funding sufficient to 
achieve the goals of the Strategy. 
‘‘(d) NATIONAL DRUG CONTROL PROGRAM BUDGET 
PROPOSAL.—For each fiscal year, following the trans-
mission of proposed drug control budget requests to the 
Director under subsection (b), the Director shall, in con-
sultation with the head of each National Drug Control 
Program Agency and the head of each major national or-
ganization that represents law enforcement officers, agen-
cies, or associations— 
‘‘(1) develop a consolidated National Drug Con-
trol Program budget proposal designed to implement 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
the National Drug Control Strategy and to inform 
Congress and the public about the total amount pro-
posed to be spent on all supply reduction, demand 
reduction, State, local, and Tribal affairs, including 
any drug law enforcement, and other drug control 
activities by the Federal Government, which shall 
conform to the content requirements set forth in 
subsection (b)(3) and include— 
‘‘(A) for each National Drug Control Pro-
gram Agency, a list of whether the funding level 
is full, partial, or insufficient to achieve the 
goals of the National Drug Control Strategy or 
whether the Director is unable to make such 
determination; 
‘‘(B) a statement describing the extent to 
which any budget of a National Drug Control 
Program Agency with less than full funding 
hinders progress on achieving the goals of the 
National Drug Control Strategy; and 
‘‘(C) alternative funding structures that 
could improve progress on achieving the goals 
of the National Drug Control Strategy; and 
‘‘(2) submit the consolidated budget proposal to 
the President and Congress. 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00026
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(e) BUDGET ESTIMATE OR REQUEST SUBMISSION 
TO CONGRESS.—Whenever the Director submits any 
budget estimate or request to the President or the Office 
of Management and Budget, the Director shall concur-
rently transmit to the appropriate congressional commit-
tees a detailed statement of the budgetary needs of the 
Office to execute its mission based on the good-faith as-
sessment of the Director. 
‘‘(f) REPROGRAMMING AND TRANSFER REQUESTS.— 
‘‘(1) IN GENERAL.—No National Drug Control 
Program Agency shall submit to Congress a re-
programming or transfer request with respect to any 
amount of appropriated funds in an amount exceed-
ing $1 million that is included in the National Drug 
Control Program budget unless the request has been 
approved by the Director. If the Director has not re-
sponded to a request for reprogramming subject to 
this paragraph within 30 days after receiving notice 
of the request having been made, the request shall 
be deemed approved by the Director under this para-
graph and forwarded to Congress. 
‘‘(2) APPEAL.—The head of any National Drug 
Control Program Agency may appeal to the Presi-
dent any disapproval by the Director of a re-
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
programming or transfer request under this sub-
section. 
‘‘§ 1005. National drug control strategy 
‘‘(a) IN GENERAL.— 
‘‘(1) STATEMENT
OF
DRUG
POLICY
PRIOR-
ITIES.—The Director shall release a statement of 
drug control policy priorities in the calendar year of 
a Presidential inauguration following the inaugura-
tion but not later than April 1. 
‘‘(2) NATIONAL
DRUG
CONTROL
STRATEGY 
SUBMITTED
BY
THE
PRESIDENT.—Not later than 
the first Monday in February following the year in 
which the term of the President commences, the 
President shall submit to Congress a National Drug 
Control Strategy. 
‘‘(b) DEVELOPMENT OF THE NATIONAL DRUG CON-
TROL STRATEGY.— 
‘‘(1) PROMULGATION.—The Director shall pro-
mulgate the National Drug Control Strategy, which 
shall set forth a comprehensive plan to reduce illicit 
drug use and the consequences of such illicit drug 
use in the United States by limiting the availability 
of and reducing the demand for illegal drugs and 
promoting prevention, early intervention, treatment, 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00028
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
and recovery support for individuals with substance 
use disorders. 
‘‘(2) STATE
AND
LOCAL
COMMITMENT.—The 
Director shall seek the support and commitment of 
State, local, and Tribal officials in the formulation 
and implementation of the National Drug Control 
Strategy. 
‘‘(3) STRATEGY BASED ON EVIDENCE.—The Di-
rector shall ensure the National Drug Control Strat-
egy is based on the best available medical and sci-
entific evidence regarding the policies that are most 
effective in reducing the demand for and supply of 
illegal drugs. 
‘‘(4) PROCESS FOR DEVELOPMENT AND SUB-
MISSION OF NATIONAL DRUG CONTROL STRATEGY.— 
In developing and effectively implementing the Na-
tional Drug Control Strategy, the Director— 
‘‘(A) shall consult with— 
‘‘(i) the heads of the National Drug 
Control Program Agencies; 
‘‘(ii) each Coordinator established 
under this chapter; 
‘‘(iii) the Interdiction Committee, the 
Treatment Committee, and the Emerging 
Threats Task Force; 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00029
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(iv) the appropriate congressional 
committees and any other committee of ju-
risdiction; 
‘‘(v) State, local, and Tribal officials; 
‘‘(vi) private citizens and organiza-
tions, including community and faith-based 
organizations, with experience and exper-
tise in demand reduction; 
‘‘(vii) private citizens and organiza-
tions with experience and expertise in sup-
ply reduction; and 
‘‘(viii) appropriate representatives of 
foreign governments; and 
‘‘(B) in satisfying the requirements of sub-
paragraph (A), shall ensure, to the maximum 
extent possible, that State, local, and Tribal of-
ficials and relevant private organizations com-
mit to support and take steps to achieve the 
goals and objectives of the National Drug Con-
trol Strategy. 
‘‘(c) CONTENTS OF THE NATIONAL DRUG CONTROL 
STRATEGY.— 
‘‘(1) IN GENERAL.—The National Drug Control 
Strategy submitted under subsection (a)(2) shall in-
clude the following: 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00030
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(A) A description of the current preva-
lence of illicit drug use in the United States, in-
cluding both the availability of illicit drugs and 
the prevalence of substance use disorders, which 
shall include the following: 
‘‘(i) Such description for the previous 
3 years for any drug identified as an 
emerging threat under section 1009 and 
any other illicit drug identified by the Di-
rector as having a significant impact on 
the prevalence of illicit drug use. 
‘‘(ii) A summary of the data and 
trends presented in the Drug Control Data 
Dashboard required under section 1013. 
‘‘(B) A mission statement detailing the 
major functions of the National Drug Control 
Program. 
‘‘(C) A list of comprehensive, research- 
based, long-range, quantifiable goals for reduc-
ing illicit drug use, including— 
‘‘(i) the percentage of the total flow of 
illicit drugs to be interdicted during the 
time period covered by the Strategy; and 
‘‘(ii) the number of individuals to re-
ceive substance use disorder treatment. 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00031
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(D) A description of how each goal estab-
lished under subparagraph (C) will be achieved, 
including for each goal— 
‘‘(i) a list of each relevant National 
Drug Control Program Agency and each 
such agency’s related programs, activities, 
and available assets and the role of each 
such program, activity, and asset in achiev-
ing such goal; 
‘‘(ii) a list of relevant stakeholders 
and each such stakeholder’s role in achiev-
ing such goal; 
‘‘(iii) an estimate of Federal funding 
and other resources needed to achieve such 
goal; 
‘‘(iv) a list of each existing or new co-
ordinating mechanism needed to achieve 
such goal; and 
‘‘(v) a description of the Office’s role 
in facilitating the achievement of such 
goal. 
‘‘(E) For each year covered by the Strat-
egy, a performance evaluation plan for each 
goal established under subparagraph (C) for 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00032
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
each National Drug Control Program Agency, 
including— 
‘‘(i) specific performance measures for 
each National Drug Control Program 
Agency and each such agency’s related 
programs and activities; 
‘‘(ii) annual and, to the extent prac-
ticable, quarterly objectives and targets for 
each performance measure; and 
‘‘(iii) an estimate of Federal funding 
and other resources needed to achieve each 
performance objective and target. 
‘‘(F) A list identifying existing data 
sources or a description of data collection need-
ed to evaluate performance, including a descrip-
tion of how the Director will obtain such data. 
‘‘(G) A list of any anticipated challenges to 
achieving the National Drug Control Strategy 
goals and planned actions to address such chal-
lenges. 
‘‘(H) A description of how each goal estab-
lished under subparagraph (C) was determined, 
including— 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00033
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
‘‘(i) a description of each required 
consultation and a description of how such 
consultation was incorporated; 
‘‘(ii) data, research, or other informa-
tion used to inform the determination to 
establish the goal; and 
‘‘(iii) for any goal established under 
subparagraph (C)(i), a statement of wheth-
er the goal will be adequate to disrupt 
drug trafficking organizations that supply 
the majority of foreign-sourced illicit drugs 
trafficked into the United States. 
‘‘(I) A 5-year projection for program and 
budget priorities. 
‘‘(J) A review of international, State, local, 
and private sector drug control activities to en-
sure that the United States pursues coordinated 
and effective drug control at all levels of gov-
ernment. 
‘‘(K) Such statistical data and information 
as the Director considers appropriate to dem-
onstrate and assess trends relating to illicit 
drug use, the effects and consequences of illicit 
drug use (including the effects on children), 
supply reduction, demand reduction, drug-re-
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
lated law enforcement, and the implementation 
of the National Drug Control Strategy. 
‘‘(2) ADDITIONAL STRATEGIES.— 
‘‘(A) IN GENERAL.—The Director shall in-
clude in the National Drug Control Strategy 
the additional strategies described under this 
paragraph and shall comply with the following: 
‘‘(i) Provide a copy of the additional 
strategies to the appropriate congressional 
committees and to the Committee on 
Armed Services and the Committee on 
Homeland Security of the House of Rep-
resentatives, and the Committee on Home-
land Security and Governmental Affairs 
and the Committee on Armed Services of 
the Senate. 
‘‘(ii) Issue the additional strategies in 
consultation with the head of each relevant 
National Drug Control Program Agency, 
any relevant official of a State, local, or 
Tribal government, and the government of 
other relevant countries. 
‘‘(iii) Not change any existing agency 
authority or construe any strategy de-
scribed under this paragraph to amend or 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
HR 5925 RFS 
modify any law governing interagency rela-
tionship but may include recommendations 
about changes to such authority or law. 
‘‘(iv) Present separately from the rest 
of any strategy described under this para-
graph any information classified under cri-
teria established by an Executive order, or 
whose public disclosure, as determined by 
the Director or the head of any relevant 
National Drug Control Program Agency, 
would be detrimental to the law enforce-
ment or national security activities of any 
Federal, State, local, or Tribal agency. 
‘‘(B) 
REQUIREMENT
FOR
SOUTHWEST 
BORDER COUNTERNARCOTICS.— 
‘‘(i) PURPOSES.—The Southwest Bor-
der Counternarcotics Strategy shall— 
‘‘(I) set forth the Government’s 
strategy for preventing the illegal traf-
ficking of drugs across the inter-
national border between the United 
States and Mexico, including through 
ports of entry and between ports of 
entry on that border; 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS